| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/27/2010 | CA2631535C Spirocyclic quinazoline derivatives as pde7 inhibitors |
| 07/27/2010 | CA2629339C Pyrazolo[4,3-d]pyrimidin-5-yl) derivative used as pde5 inhibitors |
| 07/27/2010 | CA2610166C Benzoquinolinesulfonamide derivatives useful as rho-kinase inhibitors |
| 07/27/2010 | CA2470105C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 07/27/2010 | CA2466560C Acetylene derivatives having mglur5 antagonistic activity |
| 07/27/2010 | CA2448456C Solid pharmaceutical formulations comprising modafinil |
| 07/27/2010 | CA2437587C Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotic agents |
| 07/27/2010 | CA2436659C Cannabinoid receptor ligands |
| 07/27/2010 | CA2375820C The myostatin gene promoter and inhibition of activation thereof |
| 07/27/2010 | CA2373797C Methods of treating or preventing affective disorders |
| 07/27/2010 | CA2373559C Serotonin transport inhibitors |
| 07/22/2010 | WO2010083537A2 Optimal biological marker for the biological potency of emblica officinalis gaertn. (amla) fruit-methods and products thereof |
| 07/22/2010 | WO2010083444A1 Alpha7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof |
| 07/22/2010 | WO2010083384A2 Non-peptidyl, potent, and selective mu opioid receptor antagonists |
| 07/22/2010 | WO2010083328A2 Methods for screening and compounds that protect against amyloid diseases |
| 07/22/2010 | WO2010083264A1 Novel benzenesulfonamides as calcium channel blockers |
| 07/22/2010 | WO2010083220A1 Benzoxazole inhibitors of poly(adp-ribose)polymerase |
| 07/22/2010 | WO2010083203A2 Non-embryonic stem cells and uses thereof |
| 07/22/2010 | WO2010083141A1 Bicyclic compounds for the reduction of beta-amyloid production |
| 07/22/2010 | WO2010082863A1 Method and composition for treating multiple sclerosis (variants) |
| 07/22/2010 | WO2010082837A1 Medicament for the treatment of pain and inflammation |
| 07/22/2010 | WO2010082622A1 NOVEL HIGH-FUNCTION ENZYME OBTAINED BY ALTERING SUBSTRATE SPECIFICITY OF HUMAN β-HEXOSAMINIDASE Β |
| 07/22/2010 | WO2010082601A1 Novel 2,5-disubstituted pyrrole derivative |
| 07/22/2010 | WO2010081984A1 Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules |
| 07/22/2010 | WO2010081971A1 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes |
| 07/22/2010 | WO2010081920A1 Incorporation of an emetic in drugs as a safety system in respect of possible overdoses, particularly in drugs acting on the central nervous system such as benzodiazepine and derivatives, barbiturates... and drugs for paediatric use |
| 07/22/2010 | WO2010081900A1 Quinolinone derivatives useful for the treatment of cns disorders |
| 07/22/2010 | WO2010081898A1 Novel benzotriazole derivatives useful for the treatment of cns disorders |
| 07/22/2010 | WO2010081859A1 6-phenyl-lh-imidazo [4, 5-c] pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors |
| 07/22/2010 | WO2010081825A2 Pirenzepine as an agent in cancer treatment |
| 07/22/2010 | WO2010081622A2 Food supplement for the treatment of neuropathies |
| 07/22/2010 | WO2010065743A3 Bicyclic compounds and methods of making and using same |
| 07/22/2010 | WO2010057882A3 Composition for producing anti-amyloid beta peptide antibodies with d-peptides |
| 07/22/2010 | WO2010041252A3 Use of a cinnamon bark extract for treating amyloid-associated diseases |
| 07/22/2010 | WO2010038965A3 GCH1-TARGETED si RNA, RECOMBINANT VECTOR CONTAINING si RNA, AND PHARMACEUTICAL COMPOSITION CONTAINING RECOMBINANT VECTOR FOR TREATING AND PREVENTING NEUROPATHIC PAIN |
| 07/22/2010 | WO2010036052A3 Composition containing 4-o-methylhonokiol for treating or preventing amyloid- related diseases |
| 07/22/2010 | WO2010015586A3 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
| 07/22/2010 | US20100184860 Novel Carboxylic Acid and Antidepressant Composition Containing the Same as Active Ingredient |
| 07/22/2010 | US20100184852 Organic compounds for treatment of disorders connected to impaired neurotransmission |
| 07/22/2010 | US20100184848 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 07/22/2010 | US20100184835 Devices, Systems and Methods for Improving Memory and/or Cognitive Function Through Brain Delivery of Sirna |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184824 RNA Interference Mediated Inhibition of Interleukin and Interleukin Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 07/22/2010 | US20100184819 Method for reducing intracranial pressure |
| 07/22/2010 | US20100184817 Methods of treating neuropathy |
| 07/22/2010 | US20100184809 Heterocyclic FXR Binding Compounds |
| 07/22/2010 | US20100184808 3-aza-bicyclo[3.3.0]octane compounds |
| 07/22/2010 | US20100184806 Modulation of neurogenesis by ppar agents |
| 07/22/2010 | US20100184802 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 07/22/2010 | US20100184801 Fused amino pyridines for the treatment of brain tumors |
| 07/22/2010 | US20100184797 Treatment of dyskinesia |
| 07/22/2010 | US20100184791 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/22/2010 | US20100184790 Pyrrolo[2,3-b]pyridine compounds, azaindole compounds used for synthesizing said pyrrolo[2,3-b]pyridine compounds, methods for the production thereof, and uses thereof |
| 07/22/2010 | US20100184789 Inhibitors of protein kinases |
| 07/22/2010 | US20100184787 Heataryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 07/22/2010 | US20100184783 Combination for use in the treatment of inflammatory atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist |
| 07/22/2010 | US20100184780 Inhibitors of protein kinases |
| 07/22/2010 | US20100184778 Novel heterocycle compounds and uses thereof |
| 07/22/2010 | US20100184775 Organic compounds |
| 07/22/2010 | US20100184774 Methods of treatment |
| 07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2010 | US20100184771 Bicyclic Heterocyclic Compound |
| 07/22/2010 | US20100184759 Pyrano-pyrazole-amines |
| 07/22/2010 | US20100184752 Phenothiazine compounds for treating mild cognitive impairment |
| 07/22/2010 | US20100184743 Use of cholinesterase inhibitors for treating vascular depression |
| 07/22/2010 | US20100184742 Polymorphisms in abcb1 associated with a lack of clinical response to medicaments |
| 07/22/2010 | US20100184739 Modulators of ATP-Binding Cassette Transporters |
| 07/22/2010 | US20100184738 Uses of cinnoline compounds to treat schizophrenia |
| 07/22/2010 | US20100184737 Imidazole compounds for the treatment of neurological disorders |
| 07/22/2010 | US20100184730 Fatty Acid Acylated Salicylates and Their Uses |
| 07/22/2010 | US20100184725 Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin |
| 07/22/2010 | US20100184724 Compositions for treating and/or preventing diseases characterized by the presence of metal ions |
| 07/22/2010 | US20100184718 Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells |
| 07/22/2010 | US20100184717 Treatment of Statin Side Effects Using Uridine Derivatives |
| 07/22/2010 | US20100184715 Stable salts of s-adenosylmethionine and process for the preparation thereof |
| 07/22/2010 | US20100184710 Therapeutic Bifunctional Compounds |
| 07/22/2010 | US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/22/2010 | US20100184705 Therapeutic Peptides and Vaccines |
| 07/22/2010 | US20100184704 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent |
| 07/22/2010 | US20100184701 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof |
| 07/22/2010 | US20100184698 Use of a deslorelin and mastoparan as a therapeutic agent |
| 07/22/2010 | US20100184696 Peptides and Their Use |
| 07/22/2010 | US20100184692 Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation |
| 07/22/2010 | US20100184690 Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications |
| 07/22/2010 | US20100184689 Pharmaceutical Composition Containing Botulinum Neurotoxin |
| 07/22/2010 | US20100184680 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 07/22/2010 | US20100184679 Use of a combination of cart peptides as a therapeutic agent |
| 07/22/2010 | US20100184677 Use of the human pancreatic polypeptide as a therapeutic agent |
| 07/22/2010 | US20100184675 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent |
| 07/22/2010 | US20100184674 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 07/22/2010 | US20100184673 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent |
| 07/22/2010 | US20100184659 Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents |
| 07/22/2010 | US20100184656 Pantropic neurotrophic factors |
| 07/22/2010 | US20100184650 Treating post-seizure patients |
| 07/22/2010 | US20100184646 Melanocortin receptor ligands modified with hydantoin |
| 07/22/2010 | US20100183713 Gastrointestinal-specific multiple drug release system |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183711 Pharmaceutical compositions for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis |
| 07/22/2010 | US20100183645 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 07/22/2010 | US20100183614 Immunoglobulins directed to bacterial, viral and endogeneous polypeptides |